Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Evotec is a leading partner company in drug discovery and development. With innovative technologies and comprehensive expertise, Evotec accelerates the discovery and development of new medicines for patients worldwide. The company offers tailor-made solutions in areas such as biologics, small molecules, and cell therapies.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Evotec is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Evotec last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.26 EUR.
Across its last 3 earnings reports, Evotec stock moved by ±8.7% on average the following day. The largest reaction was -17.9% on 11/05/2025; 2 of 3 reactions were positive.
Evotec has beaten analyst EPS estimates in 0 of its last 3 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.